Literature DB >> 8888067

Intermediate trapping and laue X-ray diffraction: potential for enzyme mechanism, dynamics, and inhibitor screening.

B L Stoddard1.   

Abstract

Among the many macromolecules of biomedical interest, enzyme catalysts remain important targets for the development of inhibitors and drugs, due to our ability to directly measure inhibition constants in vitro. Crystallographic structures of enzymes allow drug screening to be carried out by computational analysis of small molecules for structural and chemical complementarity to the active site. Such methods generally rely on static target structures. The development of time-resolved crystallographic methods, including trapping of reaction intermediates and Laue diffraction, allow the comparative study of enzyme conformations at different intermediate states in the catalytic cycle, providing an experimental avenue for visualizing and exploiting discrete structural states. Such methods have clear implications for mechanistic studies and possibly for computational drug design.

Mesh:

Substances:

Year:  1996        PMID: 8888067     DOI: 10.1016/0163-7258(96)00058-7

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  3 in total

1.  Coarse-grained free energy functions for studying protein conformational changes: a double-well network model.

Authors:  Jhih-Wei Chu; Gregory A Voth
Journal:  Biophys J       Date:  2007-08-17       Impact factor: 4.033

2.  Kinase conformations: a computational study of the effect of ligand binding.

Authors:  V Helms; J A McCammon
Journal:  Protein Sci       Date:  1997-11       Impact factor: 6.725

3.  Mix-and-diffuse serial synchrotron crystallography.

Authors:  Kenneth R Beyerlein; Dennis Dierksmeyer; Valerio Mariani; Manuela Kuhn; Iosifina Sarrou; Angelica Ottaviano; Salah Awel; Juraj Knoska; Silje Fuglerud; Olof Jönsson; Stephan Stern; Max O Wiedorn; Oleksandr Yefanov; Luigi Adriano; Richard Bean; Anja Burkhardt; Pontus Fischer; Michael Heymann; Daniel A Horke; Katharina E J Jungnickel; Elena Kovaleva; Olga Lorbeer; Markus Metz; Jan Meyer; Andrew Morgan; Kanupriya Pande; Saravanan Panneerselvam; Carolin Seuring; Aleksandra Tolstikova; Julia Lieske; Steve Aplin; Manfred Roessle; Thomas A White; Henry N Chapman; Alke Meents; Dominik Oberthuer
Journal:  IUCrJ       Date:  2017-10-09       Impact factor: 4.769

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.